Gene disruptions, compositions and methods relating thereto

The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO226, PRO257, PRO268, PRO290, PRO36006, PRO363, PRO365, PRO382, PRO444,...

Full description

Saved in:
Bibliographic Details
Main Authors FRANTZ GRETCHEN, MONTGOMERY CHARLES, SHI ZHENG-ZHENG, PEALE FRANKLIN, SPARKS MARY JEAN, DE SAUVAGE FREDERIC J
Format Patent
LanguageEnglish
Published 26.04.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO226, PRO257, PRO268, PRO290, PRO36006, PRO363, PRO365, PRO382, PRO444, PRO705, PRO1071, PRO1125, PRO1134, PRO1155, PRO1281, PRO1343, PRO1379, PRO1380, PRO1387, PRO1419, PRO1433, PRO1474, PRO1550, PRO1571, PRO1572, PRO1759, PRO1904, PRO35193, PRO4341, PRO4348, PRO4369, PRO4381, PRO4407, PRO4425, PRO4985, PRO4989, PRO5737, PRO5800, PRO5993, PRO6017, PRO7174, PRO9744, PRO9821, PRO9852, PRO9873, PRO10196, PRO34778, PRO20233, PRO21956, PRO57290, PRO38465, PRO38683 or PRO85161 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
AbstractList The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO226, PRO257, PRO268, PRO290, PRO36006, PRO363, PRO365, PRO382, PRO444, PRO705, PRO1071, PRO1125, PRO1134, PRO1155, PRO1281, PRO1343, PRO1379, PRO1380, PRO1387, PRO1419, PRO1433, PRO1474, PRO1550, PRO1571, PRO1572, PRO1759, PRO1904, PRO35193, PRO4341, PRO4348, PRO4369, PRO4381, PRO4407, PRO4425, PRO4985, PRO4989, PRO5737, PRO5800, PRO5993, PRO6017, PRO7174, PRO9744, PRO9821, PRO9852, PRO9873, PRO10196, PRO34778, PRO20233, PRO21956, PRO57290, PRO38465, PRO38683 or PRO85161 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
Author FRANTZ GRETCHEN
DE SAUVAGE FREDERIC J
MONTGOMERY CHARLES
PEALE FRANKLIN
SPARKS MARY JEAN
SHI ZHENG-ZHENG
Author_xml – fullname: FRANTZ GRETCHEN
– fullname: MONTGOMERY CHARLES
– fullname: SHI ZHENG-ZHENG
– fullname: PEALE FRANKLIN
– fullname: SPARKS MARY JEAN
– fullname: DE SAUVAGE FREDERIC J
BookMark eNrjYmDJy89L5WSwdk_NS1VIySwuKi0oyczPK9ZRSM7PLcgvzgTzFBLzUhRyU0sy8lOKFYpScxJLMvPSFUoyUotSS_J5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFiMtDskvjQYHNLY0NLAyMnI2MilAAAmfYxfg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Forestry
Agriculture
ExternalDocumentID US7931902B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US7931902B23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:06 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US7931902B23
Notes Application Number: US20060814549
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110426&DB=EPODOC&CC=US&NR=7931902B2
ParticipantIDs epo_espacenet_US7931902B2
PublicationCentury 2000
PublicationDate 20110426
PublicationDateYYYYMMDD 2011-04-26
PublicationDate_xml – month: 04
  year: 2011
  text: 20110426
  day: 26
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies GENENTECH, INC
RelatedCompanies_xml – name: GENENTECH, INC
Score 2.8050997
Snippet The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the...
SourceID epo
SourceType Open Access Repository
SubjectTerms AGRICULTURE
ANIMAL HUSBANDRY
CARE OF BIRDS, FISHES, INSECTS
FISHING
FORESTRY
HUMAN NECESSITIES
HUNTING
HYGIENE
MEDICAL OR VETERINARY SCIENCE
NEW BREEDS OF ANIMALS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TRAPPING
Title Gene disruptions, compositions and methods relating thereto
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110426&DB=EPODOC&locale=&CC=US&NR=7931902B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFD-etCrOL_IgfbK4dGlrkSKu3RiC23Cb7G20TTr60o62w3_fSz-mL_p2JBCSI5f7yN3vAO6FbzObRlTzjW6oMZ9R7UnnSJnS2Leo34tKtM-xOVqwt6WxbEHc1MKUOKFfJTgiSlSI8l6U7_XmJ4jllbmV-WMQ41D6Mpw7nsqbcJ90CVSv7wymE2_iqq7rLGbq-MPBa4iqT-_ja72HVrQlhWHw2ZdFKZvfGmV4AvtTXCwpTqElEgWOX9dZjYIhFDh0mzZsChzI5pk1-V5_hCNZy2R-Bs8SOZrwOM-2VYLKA5F54k0yFvETTqo-0TmpKleSNZFmnyjScyDDwdwdabi91Y4Vq8Vsd5DeBbSTNBGXQEJuUiqMyEbng1mRH5g01AMWoPFjRl3OO9D5c5mrf-au4agKoTJNN2-gXWRbcYs6uAjuSu59A-dzjEI
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNKJPihrwsw9mTy7SUYaLWYxsEFS-ImB4W7a1I7wMso3473vdB_qib5c2adpLr_fRu98B3AnXYAYNqOq2Gr7KXEbVR40jpUtjv03dZpCifY70_py9LVqLEqyKWpgUJ_QrBUdEifJR3pP0vd78BLHsNLcyfvBWOLR-7s1MW-FFuE-6BIrdMbuTsT22FMsy51Nl9GHiNUTVp3Xwtd5DC7sthaH72ZFFKZvfGqV3DPsTXCxMTqAkwiocvSyjHAVDVKFiFW3YqnAgm2fm5DD_CEcyl8n4FJ4kcjThqzjaZgkq90TmiRfJWMQNOcn6RMckq1wJl0SafSJZnwHpdWdWX8XtOTtWOPPp7iDNcyiH61DUgPhcp1S0AgOdD9YOXE-nvuYxD40fPWhwXof6n8tc_DN3C5X-bDhwBq-j90s4zMKpTNX0Kygn0VZcoz5OvJuUk9-nsI81
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Gene+disruptions%2C+compositions+and+methods+relating+thereto&rft.inventor=FRANTZ+GRETCHEN&rft.inventor=MONTGOMERY+CHARLES&rft.inventor=SHI+ZHENG-ZHENG&rft.inventor=PEALE+FRANKLIN&rft.inventor=SPARKS+MARY+JEAN&rft.inventor=DE+SAUVAGE+FREDERIC+J&rft.date=2011-04-26&rft.externalDBID=B2&rft.externalDocID=US7931902B2